1. The Texas Liver Institute, University of Texas Health, San Antonio, Texas, USA
2. Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria
3. Christian Doppler Laboratory for Portal Hypertension and Liver Fibrosis, Medical University of Vienna, Vienna, Austria
4. Metabolic Liver Research Program, I. Department of Medicine, University Medical Center Mainz, Mainz, Rhineland Palatinate, Germany
5. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany
6. Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA
7. Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany